605
Views
19
CrossRef citations to date
0
Altmetric
Drug Evaluations

Review on the clinical use of eribulin mesylate for the treatment of breast cancer

, &
Pages 589-600 | Received 27 Apr 2015, Accepted 20 Jan 2016, Published online: 17 Feb 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Isabelle Chabot, Qi Zhao & Yun Su. (2020) Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer. Current Medical Research and Opinion 36:12, pages 2025-2036.
Read now
Tengteng Zhang, Ruoming Wang, Yunbin Liu, Jisheng Huang & Zhen Yang. (2016) Efficacy and safety of doublet versus single agent as salvage treatment for metastatic breast cancer pretreated with anthracyclines and taxanes: a systematic review and meta-analysis. Current Medical Research and Opinion 32:11, pages 1883-1889.
Read now

Articles from other publishers (17)

Alberto Guijosa, Ana Freyria, Jose Rodrigo Espinosa‐Fernandez, Francisco J. Estrada‐Mena, Ana Sofía Armenta‐Quiroga, Maria Fernanda Ortega‐Treviño, Rodrigo Catalán, Bani Antonio‐Aguirre, Cynthia Villarreal‐Garza & Andric C. Perez‐Ortiz. (2022) Pharmacogenetics of taxane‐induced neurotoxicity in breast cancer: Systematic review and meta‐analysis. Clinical and Translational Science 15:10, pages 2403-2436.
Crossref
Thanushiyan Poobalasingam, Francesca Bianco, Fazal Oozeer & Phillip R. Gordon‐Weeks. (2021) The drebrin/EB3 pathway regulates cytoskeletal dynamics to drive neuritogenesis in embryonic cortical neurons. Journal of Neurochemistry 160:2, pages 185-202.
Crossref
Osama Mostafa, Mohammed Al-Shehri & Mahmoud Moustafa. (2022) Promising antiparasitic agents from marine sponges. Saudi Journal of Biological Sciences 29:1, pages 217-227.
Crossref
Mei-chen Wan, Wen Qin, Chen Lei, Qi-hong Li, Meng Meng, Ming Fang, Wen Song, Ji-hua Chen, Franklin Tay & Li-na Niu. (2021) Biomaterials from the sea: Future building blocks for biomedical applications. Bioactive Materials 6:12, pages 4255-4285.
Crossref
Noora Barzkar, Zahoor Khan, Saeid Tamadoni Jahromi, Sajjad Pourmozaffar, Mohsen Gozari & Reza Nahavandi. (2021) A critical review on marine serine protease and its inhibitors: A new wave of drugs?. International Journal of Biological Macromolecules 170, pages 674-687.
Crossref
JiaPeng He, Mao Zhang, Lv Tang, Jie liu, JiaHong Zhong, Wenya Wang, Jiang-Ping Xu, Hai-Tao Wang, Xiao-Fang Li & Zhong-Zhen Zhou. (2020) Synthesis, Biological Evaluation, and Molecular Docking of Arylpyridines as Antiproliferative Agent Targeting Tubulin. ACS Medicinal Chemistry Letters 11:8, pages 1611-1619.
Crossref
Erin P. McCauley, Ivett C. Piña, Alyssa D. Thompson, Kashif Bashir, Miriam Weinberg, Shannon L. Kurz & Phillip Crews. (2020) Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates. The Journal of Antibiotics 73:8, pages 504-525.
Crossref
Bilal A. Bhat, Showkat Rashid, Saumitra Sengupta & Goverdhan Mehta. (2020) Recent Advances in Total Synthesis of Bioactive Furo[3,2‐ b ]furanone Natural Products . Asian Journal of Organic Chemistry 9:4, pages 449-479.
Crossref
María Álvarez-Bardón, Yolanda Pérez-Pertejo, César Ordóñez, Daniel Sepúlveda-Crespo, Nestor M. Carballeira, Babu L. Tekwani, Sankaranarayanan Murugesan, Maria Martinez-Valladares, Carlos García-Estrada, Rosa M. Reguera & Rafael Balaña-Fouce. (2020) Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Marine Drugs 18:4, pages 187.
Crossref
William Jacot, Pierre‐Etienne Heudel, Julien Fraisse, Sophie Gourgou, Séverine Guiu, Florence Dalenc, Barbara Pistilli, Mario Campone, Christelle Levy, Marc Debled, Marianne Leheurteur, Marie Chaix, Claudia Lefeuvre, Anthony Goncalves, Lionel Uwer, Jean‐Marc Ferrero, Jean‐Christophe Eymard, Thierry Petit, Marie‐Ange Mouret‐Reynier, Coralie Courtinard, Paul Cottu, Mathieu Robain & Audrey Mailliez. (2019) Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. International Journal of Cancer 145:12, pages 3359-3369.
Crossref
Qinghui Wang, Kinsie E. Arnst, Yuxi Wang, Gyanendra Kumar, Dejian Ma, Stephen W. White, Duane D. Miller, Weimin Li & Wei Li. (2019) Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1 H -Indol-3-yl)-1 H -imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin . Journal of Medicinal Chemistry 62:14, pages 6734-6750.
Crossref
Renato B. Pereira, Nikolai M. Evdokimov, Florence Lefranc, Patrícia Valentão, Alexander Kornienko, David M. Pereira, Paula B. Andrade & Nelson G. M. Gomes. (2019) Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets. Marine Drugs 17:6, pages 329.
Crossref
Luis Manso, Fernando Moreno Antón, Yann Izarzugaza Perón, Juan I. Delgado Mingorance, Pablo Borrega García, María J. Echarri González, Noelia Martínez-Jañez, Ana López-González, Clara Olier Garate, Anabel Ballesteros García, Ignacio Chacón López-Muñíz, Eva Ciruelos Gil, Jose Angel García-Sáenz & Luis Paz-Ares. (2019) Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study. The Breast Journal 25:2, pages 219-225.
Crossref
Xun Li, Jie Liu, Peng-Fei Shi & Peng Fu. (2018) Katanin P80 expression correlates with lymph node metastasis and worse overall survival in patients with breast cancer. Cancer Biomarkers 23:3, pages 363-371.
Crossref
Dae-Shik Kim, Francis G. Fang, Hyeong-wook Choi & Hui Fang. (2018) Synthesis of the Halichondrin C1–C15 Fragment from a Halaven C27–C35 Byproduct: Stereospecific Intramolecular Kishi Reduction. Organic Letters 20:14, pages 4295-4297.
Crossref
Ling-Chu ChangMin-Tsang HsiehJai-Sing YangChi-Cheng LuFuu-Jen TsaiJe-Wei TsaoYu-Jen ChiuSheng-Chu KuoKuo-Hsiung Lee. (2017) Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study. International Journal of Oncology.
Crossref
Pauline Gilson, Fernando Josa-Prado, Claire Beauvineau, Delphine Naud-Martin, Laetitia Vanwonterghem, Florence Mahuteau-Betzer, Alexis Moreno, Pierre Falson, Laurence Lafanechère, Véronique Frachet, Jean-Luc Coll, Jose Fernando Díaz, Amandine Hurbin & Benoit Busser. (2017) Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties. Scientific Reports 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.